Our study further analyzed the signal pathways that may performed in the tumorigenesis and revealed the sensitivity of PCSK9 correlated with anti-tumor drugs in tumor treatment and their corresponding targets, such as PAK1, BCL2 and MDM2. This evidence concerns the gene PCSK9 and neoplasm.